Drug-induced polyneuropathy
ICD-10 Code: G62.0 · Body Part: Ankle/Foot
QME Evaluation Process
Neurological examination, EMG/NCS, medication history review. Causation analysis for medication-related neuropathy.
Typical Impairment Rating
5-20% based on deficit severity
AMA Guides Edition
5th Edition
Common Treatments
Related Conditions
Body Part Guide
Ankle/Foot Evaluation Guide
Impairment rating methods, common conditions, and QME evaluation protocols
QME Specialties for Drug-induced polyneuropathy
Find a QME Specialist
Browse QME-certified physicians who evaluate drug-induced polyneuropathy and related ankle/foot conditions in California.
Browse Physical Medicine & Rehabilitation Physicians →Frequently Asked Questions
What is Drug-induced polyneuropathy (G62.0)?
Drug-induced polyneuropathy is an ICD-10 diagnosis code (G62.0) classified under Neurological conditions. It affects the Ankle/Foot and is occasionally seen in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.
How is G62.0 rated for impairment?
The typical whole person impairment (WPI) range for Drug-induced polyneuropathy is 5-20% based on deficit severity. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.
What is the QME evaluation process for G62.0?
Neurological examination, EMG/NCS, medication history review. Causation analysis for medication-related neuropathy.
What treatments are common for Drug-induced polyneuropathy?
Common treatments for Drug-induced polyneuropathy include Medication adjustment, Pain management, Physical therapy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.